On the 22nd, the US FDA = Food and Drug Administration issued an "emergency use permission" for a drug developed by Pfizer, a major pharmaceutical company, to prevent the aggravation of the new coronavirus.
The FDA has announced that Pfizer's "Paxlobid" drug will be effective in preventing the aggravation of coronavirus infections, and will allow the drug to be used before official approval. Was issued.
The target is people over the age of 12 who are at high risk of becoming severe, and the FDA says that they should be prescribed by a doctor immediately after the infection is confirmed and should be started within 5 days.
Pfizer suppresses the growth of the virus by administering it twice a day for 5 days, and Pfizer may be hospitalized or die if administered to people at high risk of aggravation within 5 days of onset. We publish the results of clinical trials that indicate that the risk of virus is reduced by 88%.
In addition, in the experiment, it is said that the effect of suppressing the growth was also seen in the mutant virus Omicron strain.
The FDA commented, "This is the first time that a new type of coronavirus drug that can be taken in the United States has become available, and it will be a new means of fighting as the mutant virus spreads."
The United States has agreed with the company to purchase 10 million times, and the United Kingdom has announced that it will purchase 2.75 million times, and there are moves to secure it in each country.
Pfizer expects to produce 120 million batches by the end of next year.